Skip to main content

Roser Ferrer Costa

I'm the Head of Clinical Biochemistry Service at Hospital's Clinical Laboratories and co-chief of Clinical Biochemistry Group, Pharmaceutical Vehiculation and VHIR Research Therapy. I lead a team of professionals in clinical biochemistry, developing care, teaching and research, with a project towards the highest excellence. I am a PhD in Biomedicine for UB, a specialist in the area of knowledge of clinical biochemistry of hormones and a master's degree in Health Institutions Management and currently an Associate Professor of the UAB.

Institutions of which they are part

Head of group
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Head of Department
Bioquímica
Cross-departmental services

Roser Ferrer Costa

Institutions of which they are part

Head of group
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Head of Department
Bioquímica
Cross-departmental services

I'm the Head of Clinical Biochemistry Service at Hospital's Clinical Laboratories and co-chief of Clinical Biochemistry Group, Pharmaceutical Vehiculation and VHIR Research Therapy. I lead a team of professionals in clinical biochemistry, developing care, teaching and research, with a project towards the highest excellence. I am a PhD in Biomedicine for UB, a specialist in the area of knowledge of clinical biochemistry of hormones and a master's degree in Health Institutions Management and currently an Associate Professor of the UAB.

Healthcare activity:
Since 2007 I have been working at the University Hospital, where I trained as a specialist in Clinical Biochemistry (2003). I am a trained pharmacist and until 2019 I was responsible for the Hormone Process (Endocrin Pathology) of the same Service and later Head of Section of the Automated Laboratory. Since 2023, I have been Head of Clinical Biochemistry Service.

The Clinical Biochemistry Service is part of the Clinical Laboratories of the Vall d'Hebron University Hospital, which also provides coverage for the entire population, with pubic health care, of the city of Barcelona (1.5 million people).
In 2019 I completed my master's degree in Health Institutions Management, I have training in healthcare processes and specialisation in automation, concepts that I try to apply in my usual practice and in the Service. Finally, I am the secretary of the hospital's In Vitro Diagnostic Commission.

Research activity:
I am a Doctor of Biomedicine from the University of Barcelona (2015) and co-chief of Clinical Biochemistry Group, Vehiculation of Pharmacists and Therapy Research from the Research Institute of the Vall d'Hebron University Hospital since 2023. In recent years I have been actively involved in different publications of the Service itself and in collaboration with research groups and hospital services.
Attached to the eCore Personalized Medicine, Innovative Diagnostics, Molecular Imaging . Digital Health of VHIR.
I am president of the Catalan Clinical Laboratory Science Association (since June 2021) and member of the Hormone Commission (since 2011) and of the Executive Committee (since 2018) of the Spanish Society of Medicine of the Laboratory (SEQCML).

Docent Activity:
I am currently Associate Professor of the Autonomous University of the Department of Biochemistry and Molecular Biology, Medicine Biochemistry Unit.
I am participating in the postgraduate doctoral thesis management of the Biochemistry Service.

Projects

PAPEL DEL RECEPTOR DE TSH EN LOS TIMOCITOS EN EL INICIO DE LA ENFERMEDAD DE GRAVES (EG) Y MECANISMOS DE TIROIDITIS

IP: Ricardo Pujol Borrell
Collaborators: Oscar González López, Roser Ferrer Costa, Gabriel Obiols Alfonso, Ana María Marín Sánchez, Isabel Caragol Urgelles, Anna Casteras Román, Joaquin Fernandez Doblas
Funding agency: Instituto de Salud Carlos III
Funding: 80465
Reference: PI14/00848
Duration: 01/01/2015 - 31/12/2018

Efecto de la suplementación con vitamina D en la prevención de las bronquitis agudas durante el primer año de vida

IP: Antonio Moreno Galdó
Collaborators: Antonio Carrascosa Lezcano, Roser Ferrer Costa, Alba Torrent Vernetta
Funding agency: Ministerio Sanidad
Funding: 148410
Reference: EC11-476
Duration: 01/01/2012 - 31/10/2017

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

During the last year, the collaboration between Vall d’Hebron and ZeClinics has found three nanobody candidates with potent anticancer properties in zebrafish model.

Related professionals

Olga Vallès Frutuoso

Olga Vallès Frutuoso

Research technician
Multidisciplinary Nursing Research Group
Read more
Helena Isla Magrané

Helena Isla Magrané

Research technician
Ophtalmology
Read more
Javier Garcia Fernandez

Javier Garcia Fernandez

Main researcher
Multidisciplinary Nursing Research Group
Read more
Marc  Díez  García

Marc Díez García

Research technician
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.